The Most Recent Updates Regarding Construction


A sign of Foxconn is seen inside its office building in Taipei, Taiwan Nov. 12, 2020. (Reuters photo) Apple supplier to shift part of production to Vietnam Apple supplier to shift part of production to Vietnam published : 27 Nov 2020 at 14:00 A sign of Foxconn is seen inside its office building in Taipei, Taiwan Nov. 12, 2020. (Reuters photo) TAIPEI: Foxconn Technology Group is moving some iPad and MacBook assembly to Vietnam from China at the request of Apple Inc, according to a person with knowledge of the plan, as the US firm diversifies production to minimise the impact of a Sino-US trade war. The development comes as the outgoing administration of US President Donald Trump encourages US firms to shift production out of China. During Trump's tenure, the United States has targeted made-in-China electronics for higher import tariffs, and restricted supplies view publisher site of components produced using US technology to Chinese firms it deems a national security risk. Taiwanese manufacturers, wary of being caught up in the tit-for-tat trade war, have moved or are considering moving some production from China to countries such as Vietnam, Mexico and India. "Foxconn is building assembly lines for iPad tablet and MacBook laptop at its plant in Vietnam's northeastern Bac Giang province, to come online in the first half of 2021,'' the person said, declining to be identified as the plan was private. "The lines will also take some production from China,'' the person said, without elaborating how much production would shift. "The move was requested by Apple," the person said.


As part of the effort, the project has launched  to share information and resources to help educate a variety of critical audiences about the process and the science related to COVID-19 vaccines, as well as address the health inequities that exist generally and specifically with respect to COVID-19.  To learn more about the project and for details on how organizations and industry partners can get involved, click here . For a list of COVID-19 Vaccine Education and Equity Project members, to-date, click here . Statement from the COVID-19 Vaccine Education and Equity Project: "Authorized and approved COVID-19 vaccines are our best hope to protect against the virus that has singlehandedly changed everything. We expect, and believe it is important, that there be multiple vaccines for COVID-19. The COVID-19 Vaccine Education and Equity Project strives to communicate scientifically accurate information – including what we know and what we still need to learn. As we await safe and effective approved vaccines, we are committed to ensuring equitable access to information about the vaccine process." And leadership of convener organizations: Sue Peschin, President and CEO of Alliance for Aging Research: "Advancements in science and research have helped Americans live longer, healthier lives. It is especially important that older Americans, who have been hit hard by this virus, are educated on how eventual COVID-19 vaccines can help protect them." Beth Battaglino, RN-C, CEO of HealthyWomen: "Our mission is to educate and empower women to make informed decisions about their health based on accurate, evidence-based information. We want to raise awareness and drive a conversation about the need for public trust in COVID-19 vaccines and help ensure that all women have the information they need to have confidence in COVID-19 vaccines." Karyne Jones, President and CEO of National Caucus and Center on Black Aging, Inc.: "Our objective is to help people understand that vaccines are rigorously researched in order to be determined as both safe and effective. Communities of color are a priority in this work, and our aim is to grow trust. We hope this effort will help motivate them to get vaccinated, consistent with future recommendations, so they can resume their lives."  Initial support for the COVID-19 Vaccine Education and Equity Project has been provided by Pfizer, Inc.  About the COVID-19 Vaccine Education and Equity Project As leading organizations representing patients, caregivers and families, diverse communities, healthcare workers, older Americans, veterans, frontline workers and scientists, we believe we have a responsibility to come together to provide information about the clinical trials process, regulatory review, distribution of and access to potential COVID-19 vaccines in a way that promotes equity and trust.